Date of Award
Peter Ho, Ph.D.
Drug, Patent, Pharmaceutical
This paper seeks to determine if extended patent terms can positively effect the production of drugs that treat rare diseases. It reviews the structure of the modern pharmaceutical company and considers the regulatory history that lead to this structure. The paper applies historically significant economic research in the field of patents and considers patent alternatives to establish the best method for incentivizing the development of these drugs. The paper finds that while there are numerous pitfalls and issues with the patent method, there are no viable alternatives. It also concludes that extending patent terms for drugs that treat rare diseases can act as a catalyst to orphan drug development.
Copyright is held by the author. User is responsible for all copyright compliance.
Thompson, Joanna Louise, "The Case for Extending Patent Terms for Drugs That Treat Rare Diseases" (2013). Electronic Theses and Dissertations. 648.
Received from ProQuest
Joanna Louise Thompson